These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 1529875)

  • 21. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
    Sasaki T; Kubo T; Komamura K; Nishikimi T
    J Cardiol; 1999 Jun; 33(6):317-25. PubMed ID: 10396705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
    Maulik SK; Wilson V; Seth S; Bhargava B; Dua P; Ramakrishnan S; Katiyar CK
    Phytomedicine; 2016 Oct; 23(11):1211-9. PubMed ID: 26988798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.
    Webster LJ; Michelakis ED; Davis T; Archer SL
    Arch Intern Med; 2004 Mar; 164(5):514-20. PubMed ID: 15006828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.
    Fitton A; Brogden RN
    Drugs Aging; 1994 May; 4(5):417-41. PubMed ID: 8043944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.
    Xian SX; Yang ZQ; Ren PH; Ye XH; Ye SL; Wang QH; Wang ZH; Shen SJ; Huang XW
    Chin J Integr Med; 2015 Oct; 21(10):733-42. PubMed ID: 25948124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM; Rush JE; Laste NJ; Malakoff RL; Cunningham SM; Aronow N; Hall DJ; Williams J; Price LL
    J Vet Cardiol; 2011 Dec; 13(4):251-60. PubMed ID: 22030289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of pimobendan on peripheral hemodynamics].
    Peters P; Saborowski F; Kothe A
    Z Kardiol; 1989 Aug; 78(8):538-44. PubMed ID: 2678794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    Littler WA; Sheridan DJ
    Br Heart J; 1995 May; 73(5):428-33. PubMed ID: 7786657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
    Kawano H; Arakawa S; Satoh O; Matsumoto Y; Hayano M; Nakatomi D; Yamasa T; Maemura K
    Geriatr Gerontol Int; 2014 Jan; 14(1):109-14. PubMed ID: 23581555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Hagemeijer F; Brand HJ; van Mechelen R
    Am J Cardiol; 1989 Mar; 63(9):571-6. PubMed ID: 2919561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure.
    Hagemeijer F
    Eur Heart J; 1993 Apr; 14(4):551-66. PubMed ID: 8472722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of imazodan for treatment of chronic congestive heart failure. The Imazodan Research Group.
    Goldberg AD; Nicklas J; Goldstein S
    Am J Cardiol; 1991 Sep; 68(6):631-6. PubMed ID: 1715125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE; Rush JE; Luis Fuentes V; Glaus T; Summerfield NJ; Wright K; Lehmkuhl L; Wess G; Sayer MP; Loureiro J; MacGregor J; Mohren N
    J Vet Intern Med; 2021 Mar; 35(2):789-800. PubMed ID: 33543810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP; Oikarinen L; Toivonen L; Jurkko R; Puttonen J; Sarapohja T; Sundberg S; Nieminen MS
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A; Häggström J; Gordon SG; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Watson P
    J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
    Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study.
    Klein S; Nolte I; Rumstedt K; Sehn M; Raue JF; Weiner F; Treese JS; Beyerbach M; Bach JP
    BMC Vet Res; 2021 Sep; 17(1):310. PubMed ID: 34563187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure.
    Kostis JB; Rosen RC; Cosgrove NM; Shindler DM; Wilson AC
    Chest; 1994 Oct; 106(4):996-1001. PubMed ID: 7924541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF; Grom E; Jähnchen E; Roskamm H
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial.
    Rector TS; Carson PE; Anand IS; McMurray JJ; Zile MR; McKelvie RS; Komajda M; Kuskowski M; Massie BM;
    Circ Heart Fail; 2012 Mar; 5(2):217-25. PubMed ID: 22267751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.